Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Marks

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Cell Cycle (Georgetown, Tex.)|February 28, 2013
MicroRNAs and the cellular response to rapamycin: potential role in diagnosis and therapyHana Totary-Jain, Andrew R Marks
Cell Calcium|July 5, 2022
Catching the next wave of recombinant RyR2 cryo-EM structures. Commentary on "Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations"Marco C Miotto, Andrew R Marks
The Journal of Clinical Investigation|May 4, 2006
Why we think it is important to discuss intelligent designUshma S Neill, Andrew R Marks
Basic Research in Cardiology|December 14, 2002
Regulation of the ryanodine receptor in heart failureSteven O Marx, Andrew R Marks
Expert Opinion on Therapeutic Targets|September 20, 2006
Phosphodiesterase 4D and heart failure: a cautionary taleStephan E Lehnart, Andrew R Marks
Pflugers Archiv : European Journal of Physiology|February 25, 2010
Ryanodine receptor channelopathiesMatthew J Betzenhauser, Andrew R Marks
Annual Review of Medicine|January 30, 2004
Drug-eluting stentsT Cooper Woods, Andrew R Marks
Annals of Medicine|June 5, 2004
Molecular determinants of altered contractility in heart failureXander H T Wehrens, Andrew R Marks
Nature Reviews. Drug Discovery|July 3, 2004
Novel therapeutic approaches for heart failure by normalizing calcium cyclingXander H T Wehrens, Andrew R Marks
Biochimica Et Biophysica Acta. Molecular Cell Research|July 25, 2018
Ryanodine receptor dysfunction in human disordersAlexander Kushnir, Benjamin Wajsberg, Andrew R Marks
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Cell Cycle (Georgetown, Tex.)|February 28, 2013
MicroRNAs and the cellular response to rapamycin: potential role in diagnosis and therapyHana Totary-Jain, Andrew R Marks
Cell Calcium|July 5, 2022
Catching the next wave of recombinant RyR2 cryo-EM structures. Commentary on "Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations"Marco C Miotto, Andrew R Marks
The Journal of Clinical Investigation|May 4, 2006
Why we think it is important to discuss intelligent designUshma S Neill, Andrew R Marks
Basic Research in Cardiology|December 14, 2002
Regulation of the ryanodine receptor in heart failureSteven O Marx, Andrew R Marks
Expert Opinion on Therapeutic Targets|September 20, 2006
Phosphodiesterase 4D and heart failure: a cautionary taleStephan E Lehnart, Andrew R Marks
Pflugers Archiv : European Journal of Physiology|February 25, 2010
Ryanodine receptor channelopathiesMatthew J Betzenhauser, Andrew R Marks
Annual Review of Medicine|January 30, 2004
Drug-eluting stentsT Cooper Woods, Andrew R Marks
Annals of Medicine|June 5, 2004
Molecular determinants of altered contractility in heart failureXander H T Wehrens, Andrew R Marks
Nature Reviews. Drug Discovery|July 3, 2004
Novel therapeutic approaches for heart failure by normalizing calcium cyclingXander H T Wehrens, Andrew R Marks
Biochimica Et Biophysica Acta. Molecular Cell Research|July 25, 2018
Ryanodine receptor dysfunction in human disordersAlexander Kushnir, Benjamin Wajsberg, Andrew R Marks
Pageof 18